Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GERCOR - Multidisciplinary Oncology Cooperative Group
With
HalioDx
Methodology and quality of life unit in oncology, University hospital of Besancon
Adult patients of both genders who have underwent surgical resection of stage III colon carcinoma and randomised to receive a 6-month or 3-month adjuvant therapy with modified FOLFOX 6 or CAPOX in the IDEA France trial.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient and tumor characteristics; 3-year clinical Follow-Up
Data regarding other markers (eg. MSI)
FFPE blocks available, including core tumor + invasive margin regions
You may not be if
Bouin fixative
Sample type:
adjacent FFPE slices (4 μm each) per case (although only one slide is required for CD3 and one for CD8, with center of tumor (CT) and the invasive margin(IM) cut from FFPE blocks no more than 4 months before the Immunoscore® testing
Clareo Health | Prognostic Value of the Immunoscore® Colon Test for Disease Free Survival Stratification in Stage III Patients Under Oxaliplatin Treatment
